185347-31-3

Upstream product

• 64-17-5 ethanol 
• 1760-84-5 2-hydroxy-3-acetyl-5-bromobenzoic acid 

Downstream Products

• 205875-66-7 1-(5-bromo-3-ethoxycarbonyl-2-hydroxyphenyl)-3-(3-isopropoxy)phenyl-1,3-propanedione 
• 207617-55-8 6-Bromo-2-(3,5-dihydroxy-phenyl)-4-oxo-4H-chromene-8-carboxylic acid ethyl ester 
• 207617-51-4 6-Bromo-2-(3,5-dimethoxy-phenyl)-4-oxo-4H-chromene-8-carboxylic acid 
• 207617-53-6 6-Bromo-2-(3,5-dihydroxy-phenyl)-4-oxo-4H-chromene-8-carboxylic acid 
• 205045-50-7 6-bromo-8-ethoxycarbonyl-3'-isopropoxyflavone 
• 205045-51-8 6-bromo-8-ethoxycarbonyl-3'-hydroxyflavone 
• 207617-49-0 1-(5-bromo-3-ethoxycarbonyl-2-hydroxyphenyl)-3-(3,5-dimethoxyphenyl)propane-1,3-dione 
• 1027523-32-5 5-Bromo-2-hydroxy-3-(3-oxo-3-quinolin-2-yl-propionyl)-benzoic acid ethyl ester 

Relevant academic research and scientific papers

Synthesis and structure - Activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists

The synthesis and CysLT1 receptor affinities of a new series of highly rigid 3'- and 4-'(2-quinolinylmethoxy)- or 3'- an 4-'[2-(2- quinolinyl)ethenyl]-substituted, 6-, 7-, or 8-carboxylated flavones are described. CysLT1 receptor aff